斯库特拉林通过肠道微生物介导的cAMP/PKA/NF-κB通路缓解了性结肠炎
Yang Li1, Mengdan Yan1, Miao Zhang1
1School of Medical Technology, Jiangsu College of Nursing, Huai'an, 223001, PR China.
Biochemical and biophysical research communications
|October 18, 2024
概括
斯库特拉林通过调节肠道微生物群和激活cAMP/PKA/NF-κB通路来显示出性结肠炎 (UC) 的治疗潜力. 这种天然化合物通过减少炎症和改善肠道健康,为UC治疗提供了有前途的方法.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 微生物学 微生物学
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病,有效治疗方法有限.
- 斯库特拉林是一种天然化合物,已显示出治疗潜力,但其在UC中的机制尚未完全理解.
研究的目的:
- 在UC的小鼠模型中评估scutellarin的治疗疗效.
- 阐明scutellarin作用的潜在机制,重点关注肠道微生物群和分子通路.
主要方法:
- 德克斯硫酸 (DSS) 诱导的UC小鼠模型.
- 抗生素尾酒 (ABX) 和便微生物群移植 (FMT),以调查肠道微生物群的作用.
- 便代谢学和网络药理学分析,以探索分子机制.
主要成果:
- 斯库特拉林缓解了UC症状,包括体重减轻和结肠炎症.
- 斯库特拉林的使用改善了肠道微生物群的组成,并减轻了失调的代谢物.
- 网络药理学发现cAMP/PKA/NF-κB通路对于scutellarin的治疗效果至关重要.
结论:
- 斯库特拉林在性结肠炎中显示出显著的治疗潜力.
- 该机制涉及肠道微生物群衍生代谢物的调节和cAMP/PKA/NF-κB通路的激活.
- 斯库特拉林是UC管理的有前途的天然治疗剂.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
124
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
124
Inflammatory Bowel Disease V: Surgical Management
125
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
125
Inflammatory Bowel Disease I: Ulcerative Colitis
146
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
146
Inflammatory Bowel Disease IV: Pharmacological Management
117
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
117
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
322
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
322
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
97
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
97


